1. Prognostic Value of Proliferation, Apoptosis, Defective DNA Mismatch Repair, and p53 Overexpression in Patients With Resected Dukes' B2 or C Colon Cancer
   Megan M. Garrity et al, 2004, Journal of Clinical Oncology CrossRef
2. Targeting mutant p53-R248W reactivates WT p53 function and alters the onco-metabolic profile
   Kate Brown et al, 2023, Frontiers in Oncology CrossRef
3. The TP53 Colorectal Cancer International Collaborative Study on the Prognostic and Predictive Significance of p53 Mutation: Influence of Tumor Site, Type of Mutation, and Adjuvant Treatment
   Antonio Russo et al, 2005, Journal of Clinical Oncology CrossRef
4. Determination of TP53 Mutation Is More Relevant Than Microsatellite Instability Status for the Prediction of Disease-Free Survival in Adjuvant-Treated Stage III Colon Cancer Patients
   Jantine L. Westra et al, 2005, Journal of Clinical Oncology CrossRef
5. Induction of HSF1 expression is associated with sporadic colorectal cancer
   Hui Cen, 2004, World Journal of Gastroenterology CrossRef
6. Inhibition of protein kinase C delta leads to cellular senescence to induce anti‐tumor effects in colorectal cancer
   Yuya Shimoyama et al, 2023, Cancer Science CrossRef